Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

bone scan

  • Adverse Clinical Events at the Injection Site Are Exceedingly Rare After Reported Radiopharmaceutical Extravasation in Patients Undergoing <sup>99m</sup>Tc-MDP Whole-Body Bone Scintigraphy: A 12-Year Experience
    Open Access
    Adverse Clinical Events at the Injection Site Are Exceedingly Rare After Reported Radiopharmaceutical Extravasation in Patients Undergoing 99mTc-MDP Whole-Body Bone Scintigraphy: A 12-Year Experience
    Ashwin Singh Parihar, Lisa R. Schmidt, John Crandall, Farrokh Dehdashti and Richard L. Wahl
    Journal of Nuclear Medicine March 1, 2023, 64 (3) 485-490; DOI: https://doi.org/10.2967/jnumed.122.264994
  • The Prognostic Value of Quantitative Bone SPECT/CT Before <sup>223</sup>Ra Treatment in Metastatic Castration-Resistant Prostate Cancer
    You have access
    The Prognostic Value of Quantitative Bone SPECT/CT Before 223Ra Treatment in Metastatic Castration-Resistant Prostate Cancer
    Helmut Dittmann, Sabine Kaltenbach, Matthias Weissinger, Francesco Fiz, Peter Martus, Maren Pritzkow, Juergen Kupferschlaeger and Christian la Fougère
    Journal of Nuclear Medicine January 1, 2021, 62 (1) 48-54; DOI: https://doi.org/10.2967/jnumed.119.240408
  • You have access
    Assessing Radiographic Response to 223Ra with an Automated Bone Scan Index in Metastatic Castration-Resistant Prostate Cancer Patients
    Aseem Anand, Elin Trägårdh, Lars Edenbrandt, Lars Beckman, Jan-Henry Svensson, Camilla Thellenberg, Anders Widmark, Jon Kindblom, Anders Ullén and Anders Bjartell
    Journal of Nuclear Medicine May 1, 2020, 61 (5) 671-675; DOI: https://doi.org/10.2967/jnumed.119.231100
  • You have access
    Intraindividual Comparison of 99mTc-Methylene Diphosphonate and Prostate-Specific Membrane Antigen Ligand 99mTc-MIP-1427 in Patients with Osseous Metastasized Prostate Cancer
    Hendrik Rathke, Ali Afshar-Oromieh, Frederik Lars Giesel, Christophe Kremer, Paul Flechsig, Sabine Haufe, Walter Mier, Tim Holland-Letz, Maximilian De Bucourt, Thomas Armor, John W. Babich, Uwe Haberkorn and Clemens Kratochwil
    Journal of Nuclear Medicine September 1, 2018, 59 (9) 1373-1379; DOI: https://doi.org/10.2967/jnumed.117.200220
  • You have access
    68Ga-PSMA-11 PET as a Gatekeeper for the Treatment of Metastatic Prostate Cancer with 223Ra: Proof of Concept
    Hojjat Ahmadzadehfar, Kambiz Azgomi, Stefan Hauser, Xiao Wei, Anna Yordanova, Florian C. Gaertner, Stefan Kürpig, Holger Strunk and Markus Essler
    Journal of Nuclear Medicine March 1, 2017, 58 (3) 438-444; DOI: https://doi.org/10.2967/jnumed.116.178533
  • You have access
    A Preanalytic Validation Study of Automated Bone Scan Index: Effect on Accuracy and Reproducibility Due to the Procedural Variabilities in Bone Scan Image Acquisition
    Aseem Anand, Michael J. Morris, Reza Kaboteh, Mariana Reza, Elin Trägårdh, Naofumi Matsunaga, Lars Edenbrandt, Anders Bjartell, Steven M. Larson and David Minarik
    Journal of Nuclear Medicine December 1, 2016, 57 (12) 1865-1871; DOI: https://doi.org/10.2967/jnumed.116.177030
  • You have access
    Analytic Validation of the Automated Bone Scan Index as an Imaging Biomarker to Standardize Quantitative Changes in Bone Scans of Patients with Metastatic Prostate Cancer
    Aseem Anand, Michael J. Morris, Reza Kaboteh, Lena Båth, May Sadik, Peter Gjertsson, Milan Lomsky, Lars Edenbrandt, David Minarik and Anders Bjartell
    Journal of Nuclear Medicine January 1, 2016, 57 (1) 41-45; DOI: https://doi.org/10.2967/jnumed.115.160085
  • You have access
    Comparison of Prostate-Specific Membrane Antigen–Based 18F-DCFBC PET/CT to Conventional Imaging Modalities for Detection of Hormone-Naïve and Castration-Resistant Metastatic Prostate Cancer
    Steven P. Rowe, Katarzyna J. Macura, Anthony Ciarallo, Esther Mena, Amanda Blackford, Rosa Nadal, Emmanuel S. Antonarakis, Mario A. Eisenberger, Michael A. Carducci, Ashley E. Ross, Philip W. Kantoff, Daniel P. Holt, Robert F. Dannals, Ronnie C. Mease, Martin G. Pomper and Steve Y. Cho
    Journal of Nuclear Medicine January 1, 2016, 57 (1) 46-53; DOI: https://doi.org/10.2967/jnumed.115.163782
  • You have access
    Multitargeted Tyrosine Kinase Inhibition Produces Discordant Changes Between 99mTc-MDP Bone Scans and Other Disease Biomarkers: Analysis of a Phase II Study of Sunitinib for Metastatic Castration-Resistant Prostate Cancer
    Philip J. Saylor, Umar Mahmood, Anchisa Kunawudhi, Matthew R. Smith, Edwin L. Palmer and M. Dror Michaelson
    Journal of Nuclear Medicine November 1, 2012, 53 (11) 1670-1675; DOI: https://doi.org/10.2967/jnumed.112.105007
SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire